Dr. Farahin Mohd Jais is a senior lecturer in the Department of Civil Engineering. She was a previous recipient of the Programme Mahasiswa Cemerlang under the JPA scholarship during her Master's in Engineering of Science (Environmental) studies, and later pursued her Ph.D. in Environmental Engineering under the Skim Latihan Akademik Bumiputera (SLAB) fellowship. She specialized in water and wastewater treatment, with a focus on removing conventional and emerging water pollutants using carbon materials made from biomass waste. To date, she has synthesized water/wastewater treatment materials from a variety of biomass wastes, including spent coffee bean waste, pineapple leaf waste, palm shell waste, and sugarcane bagasse. Her experience in using adsorption technology for water/wastewater treatment has sparked her interest in diversifying into other technology including catalysis and membrane filtration.

Academician Datuk Professor Dr Lai-Meng Looi is Malaysia’s inaugural National Distinguished Professor, positioned at  the Faculty of Medicine, University of Malaya (UM).  She holds a concurrent appointment as senior consultant histopathologist at the University of Malaya Medical Centre (UMMC).    Professor Looi studied medicine as a Malaysian Federal Scholar at the University of Singapore (1970-1975), where she was a medalist in Pathology and Social Medicine, and won King Edward VII Hall awards for literary works, art forms and poetry.  She trained in Surgical Pathology at UM, Royal Postgraduate Medical School (UK) and Brigham and Woman’s Hospital, Boston, (USA) and defended her research doctorate (on amyloidosis) at UM.  She assumed the Chair of Pathology, UM at the age of 36 years and during her long academic career at UM has served as Department Head, Deputy Dean (Postgraduate), Chair of the Medical Centre Research Committee, representative to the Malaysian Medical Council, Chair of the Medical Advisory Committee of UMMC and UM’s Committee for External Academic Evaluators.  She continues to chair the UMMC-Medical Research Ethics Committee/ Institutional Review Board.  She has more than 200 peer-reviewed publications, mainly on amyloidosis, nephropathology and oncopathology, is devoted to promoting a research and ethical culture among researchers, has delivered >500 guest lectures and conducts scientific writing workshops nationally and internationally. Professor Looi is a Foundation Fellow and Academician of the Academy of Sciences Malaysia (ASM) and has served as Chief Censor and Scribe of the Academy of Medicine Malaysia.   She has served as  Editor-in-Chief of the Malaysian Journal of Pathology, on the International Editorial Advisory Boards of Pathology, Journal of Pathology, Human Pathology and Histopathology, is Founding Vice-President of the Association of Malaysian Medical Journal Editors, and chaired the Ethics and Editorial Policies Committee of Asia-Pacific Association of Medical Editors.   A Fellow of both Royal Colleges of Pathologists, UK (RCPath) and Australasia (RCPA), she served as Examiner and Advisor to both.  She is the Founding President of the College of Pathologists, Academy of Medicine Malaysia, and was instrumental in developing pathology laboratory accreditation for Malaysia, the Pathology Act and several National guidelines on medical laboratory practices.  In 2010 she was honoured RCPA Distinguished Fellow and Inaugural National Distinguished Professor (Profesor Ulung Negara).  She was President of the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM) from 2013-2016, and chaired its Education Committee which focusses on capacity-building in countries-in-need.   She co-chaired the InterAcademy Medical Panel (now the InterAcademy Partnership for Health) for two elected terms (2010-2016) and currently represents ASM in its Executive Committee.   During her chairmanship, this global network of National Sciences and Medical Academies extended its initiatives into global health, the social determinants of health, urban health, and young physician leadership capacity-building. She chaired the ASM Newton-Ungku Omar Fund Committee for Bilateral Research Programmes with the Medical Research Council, UK. (2015-2018) and the 2019 MRC-Malaysia Joint Panel on Non-Communicable Diseases. She is a Member of the MRC (UK) Applied Global Health Research Board, and the InterAcademy Partnership Expert Working Group on Harnessing the World's Academies to combat predatory journals and conferences.  She is a Commissioner for the Lancet Commission on Diagnostics. Her contributions to research, education and medical science have been recognised with several accolades including the Panglima Jasa Negara (Datuk), Sri Indera Mahkota Pahang (Dato Indera), National Science Award, ASEAN Outstanding Scientist Award,  Merdeka Award 2016 (Health, Science and Technology category),  WASPaLM’s Gold-Headed Cane and Honorary Professor of the Chinese Academy of Medical Sciences-Peking Union Medical College. She was named in Stanford University's list of the World Top 2% Scientists 2022. 

I am a researcher in human genetics specialising in copy number variations (CNVs) and the impacts of such genetic variations in human health. I am equipped with a comprehensive research background which include biotechnology (BSc), human molecular genetics, population genetics, genomics, cytogenetics, molecular and cellular biology, bioinformatics, high-performance computing and biostatistics (MSc, PhD). My aim is always to promote wellness and lifestyle solutions through scientifically-driven values and tools in providing personalised disease screenings, therapeutics and preventive strategies, specifically using structural genomic variations (and other genetic variations) as potential therapeutic and screening targets for non-communicable diseases, also known as NCDs (i.e. cancer, obesity, diabetes). As an educator, I always believe in the importance of education to create long-lasting awareness in health.  Specifically, I am interested to investigate differential patterns of structural genomic variations in order to identify the plausible causes, or origins of NCDs in our Malaysian population. I am fascinated by the diversity of our ethnic composition and intrigued to see the genetic patterns of such diverse background. Given the opportunity and the right collaborations, it is hoped that together, we could delineate the genomic architecture of our unique population, which could eventually provide more informative data that are beneficial in our fight against such diseases. My previous work thus far has involved the integration of various bioinformatics components in genetic analytics, and I would like to continue doing so since big data technology is becoming a norm in current and future biological scientific research.